Skip to content
Screener

Materion MTRN Life sciences — Net Sales

Other product segments

Semiconductor
$305.13M+58.9%
Aerospace and defense
$74.67M+40.1%
Consumer electronics
$60.16M+0.2%
Industrial
$56.28M+23.0%
Energy
$52.8M+106%
Other
$31.13M+53.4%
Automotive
$20.52M+0.3%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOLife Science — Net Sales
$228.5M0.0%
GLW
GLWLife Science Products — Net Sales
$249M+1.2%
Donaldson Company logo
DCILife Sciences Segment — Net Sales
$83.5M+12.5%
IDEX logo
IEXHealth & Science Technologies — Net Sales
$415M+13.6%
Baxter International logo
BAXFront Line Care — Net Sales
$270M-2.5%
Daktronics logo
DAKTLive Events — Net Sales
$84.86M+42.4%

Other financials

Income statement

See full
Revenue$613.9M+42.2%
Gross profit$104.3M+26.2%
Operating income$51.7M+40.4%
Net income$38.8M+54.2%
EPS (diluted)$1.84+52.1%

Balance sheet

See full
Cash & equivalents$20.0M+58.7%
Total debt$511.5M0.0%
Total equity$994.9M+9.2%
Total assets$1.9B+7.4%

Cash flow

See full
Operating cash flow$74.8M+49.8%
CapEx$14.5M+14.6%
Free cash flow$60.3M+61.8%

Valuation

See full
Market cap$5.8B+156%
Enterprise value$6.29B+128%
P/E64.3×
P/S2.8×+1.5×

Profitability

See full
Gross margin16%-3.3pp
Operating margin6%
Net margin4.3%
FCF margin2.4%-2.9pp

Returns & leverage

See full
Return on equity9.5%
Debt / equity0.5×0.0×
Current ratio2.9×-0.2×

Where this comes from

Reported directly by Materion in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Materion’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:59 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104657-26-000044
(Thousands) / Second Quarter 2026Performance MaterialsElectronic MaterialsPrecision OpticsOtherTotal
Consumer electronics46,45210,4623,24660,160
Automotive18,2822541,97920,515
Energy15,58237,21452,796
Life sciences1,8565,8355,53313,224
Other26,4024,73031,132
Total$207,949$375,181$30,776$613,906
Second Quarter 2025
End Market

Item 1. Financial Statements

FAQ

What is Materion's life sciences — net sales?
Materion (MTRN) reported life sciences — net sales of $13.22M in Q2 2026.
How has Materion's life sciences — net sales changed year-over-year?
Materion's life sciences — net sales decreased by 5.9% year-over-year, from $14.05M to $13.22M.
What is the long-term trend for Materion's life sciences — net sales?
Over 4 years (2021 to 2025), Materion's life sciences — net sales has grown at a -3.4% compound annual growth rate (CAGR), from $53.68M to $46.78M.
What does life sciences — net sales mean?
This metric represents the total revenue generated from products and services specifically tailored for the life sciences sector, including medical devices, diagnostic equipment, and biotechnology applications. It serves as a key indicator of the company's penetration into high-growth healthcare and clinical markets. Tracking this revenue stream helps investors assess the diversification of the company's material science portfolio beyond traditional industrial and electronic applications.

Ask your AI about Materion's life sciences — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude